Presentation TCT 2016 When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy? Presenter: Roxana Mehran November 01, 2016 REGISTER for free or LOG IN to view this content Heart Rhythm Presentation TCT 2016 Atrial Fibrillation Up Next Presentation TCT 2016 Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI Presenter: Deepak L. Bhatt November 01, 2016 More slides + Presentation TCT 2016 The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status Presenter: C. Michael Gibson November 01, 2016 Presentation TCT 2016 The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status Presenter: Pascal Vranckx November 01, 2016 We Recommend
Presentation TCT 2016 Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI Presenter: Deepak L. Bhatt November 01, 2016
Presentation TCT 2016 The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status Presenter: C. Michael Gibson November 01, 2016
Presentation TCT 2016 The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status Presenter: Pascal Vranckx November 01, 2016